Clonidine and ADHD
Links shared publicly online about this topic
Forums: Clonidine Adhd - Clonidine No Prescription Needed. - PlayFirst Games
playfirst.com — “Forums: Clonidine Adhd - Clonidine No Prescription Needed. - PlayFirst Games” View full resource at playfirst.com
Most Recently Shared on March 13, 2012 at 11:26 am By:
Forums: Clonidine Adhd - Clonidine No Prescription Needed ... http://t.co/pmdqUzu9
Study: Clonidine plus stimulant is effective for ADHD - Related Stories - AAP SmartBrief
smartbrief.com — “A study in Pediatrics found that adding extended-release clonidine to stimulant therapy significantly improved symptoms in young patients with ADHD after eight weeks of treatmen--” View full resource at smartbrief.com
Most Recently Shared on May 13, 2011 at 6:22 am By:
Study: Clonidine plus stimulant is effective for ADHD http://sbne.ws/r/7Nfs
Clonidine extended-release: in attention-defi... [Paediatr Drugs. 2011] - PubMed - NCBI
ncbi.nlm.nih.gov — “PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on September 13, 2011 at 5:52 pm By:
Clonidine extended-release: in attention-deficit hyperactivity disorder.: Authors: Croxtall JD Abstrac... http://t.co/d3C9RKj #adhd
Shionogi Inc. Announces Commercial Availability of KAPVAY™ (clonidine hydrochloride) Extended-Release Tablets... -- FLORHAM PARK, N.J., Jan. 10, 2011 /PRNewswire/ --
prnewswire.com — “Shionogi Inc. Announces Commercial Availability of KAPVAY™ (clonidine hydrochloride) Extended-Release Tablets for the Treatment of ADHD.” View full resource at prnewswire.com
Most Recently Shared on January 10, 2011 at 3:00 pm By:
Peter H Brown Doctor and Psychologist
Shionogi Inc. Announces Commercial Availability of KAPVAYâ„¢ (clonidine ... http://bit.ly/eEqTNr #ADHD
First ADHD Add-On Drug Approved | Psych Central News
psychcentral.com — “The U.S. Food and Drug Administration (FDA) has given the green light to the nonstimulant medication Kapvay (clonidine hydrochloride) as the first drug used to” View full resource at psychcentral.com
Most Recently Shared on October 7, 2010 at 2:36 pm By:
Peter H Brown Doctor and Psychologist
First ADHD Add-On Drug Approved http://bit.ly/caL9Ct #ADHD
Shionogi Announces FDA Approval Of KAPVAY™ - The First And Only Therapy Approved For Use With Stimulant Medication For The Treatment Of ADHD
medicalnewstoday.com — “Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., announced the U.S. Food and Drug Administration approval of the non-stimulant medication KAPVAY™ (clonidine hydrochloride” View full resource at medicalnewstoday.com
Most Recently Shared on October 6, 2010 at 3:05 pm By:
MNT ADHD & ADD News Health News
Shionogi Announces FDA Approval Of KAPVAY™ - The First And Only Therapy Approved For Use With Stimulant Medicati... http://mnt.to/3KPx
Shionogi Announces FDA Approval of Kapvay - The First and Only Therapy Approved for Use with Stimulant Medication for the Treatment of ADHD
drugs.com — “Kapvay (clonidine hydrochloride) is used to treat Attention Deficit Hyperactivity Disorder (ADHD). Includes Kapvay side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 4, 2010 at 11:57 pm By:
FDA Approves Kapvay for the Treatment of ADHD - http://bit.ly/9mCUK6
Michael Riley on Trial | Rebecca Riley | Bipolar Beat | Bipolar Beat
blogs.psychcentral.com — “Michael Riley is on trial for the murder of his daughter Rebecca Riley, who allegedly died of an overdose of prescription medication used to treat bipolar and ADHD.” View full resource at blogs.psychcentral.com
Most Recently Shared on March 10, 2010 at 6:39 pm By:
Bipolar Beat: Rebecca Riley’s Father on Trial http://bit.ly/9Uwp9y
Table of Contents - 2011 - The Brown University Child & Adolescent Psychopharmacology Update - Wiley Online Library
onlinelibrary.wiley.com — “Table of Contents - 2011 - The Brown University Child & Adolescent Psychopharmacology Update - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on June 27, 2011 at 6:37 pm By:
Table of Contents: AbstractClonidine Extended Release Augmentation of Psychostimulants in ADHDADHD a Risk ... http://bit.ly/j750te #adhd
Kapvay approved for ADHD - MPR
empr.com — “The FDA has approved Kapvay (clonidine HCl extended-release tablets, from Shionogi) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents ages 6"17 years old.” View full resource at empr.com
Most Recently Shared on October 4, 2010 at 3:00 pm By:
MPR News: Kapvay approved for ADHD: The FDA has approved Kapvay (clonidine HCl extended-release tablets, from Shio... http://bit.ly/9MiFxk
Extended-release tab --for ADHD - The Clinical Advisor
clinicaladvisor.com — “This formulation of clonidine is indicated for treating patients with ADHD, either as monotherapy or as adjunctive therapy to stimulant medications. It has not been studied in adults.” View full resource at clinicaladvisor.com
Most Recently Shared on March 24, 2011 at 1:31 pm By:
Peter H Brown Doctor and Psychologist
Extended-release tab for ADHD http://bit.ly/e748vu #ADHD
Drug Combo May Help Treat Kids With ADHD
m.webmd.com — “Combining an extended-release version of the blood pressure pill clonidine with a stimulant may benefit children with attention deficit hyperactivity disorder (ADHD) who are not getting adequate relief from stimulants alone, according to a new study.” View full resource at m.webmd.com
Most Recently Shared on May 12, 2011 at 6:43 pm By:
Drug Combo May Help Treat Kids With ADHD: Combining an extended-release version of the blood pressure pill... http://bit.ly/mvZYav #adhd
Phase 3 Study of Kapvay for ADHD - MPR
empr.com — “Shionogi Inc. announced thatdata from its Phase 3 study of Kapvay (clonidine hydrochloride) extended-release tablets combined with stimulant medications for the treatment of attention deficit hyperactivity disorder in children and adolescents 6-17 years of age.” View full resource at empr.com
Most Recently Shared on May 9, 2011 at 3:18 pm By:
MPR News: Phase 3 Study of Kapvay for ADHD: Shionogi Inc. announced that data from its Phase 3 study of Kapvay (... http://bit.ly/jBLDDp
Kapvay available for ADHD - ONA
oncologynurseadvisor.com — “Shionogi announced the availability of Kapvay (clonidine HCl extended-release tablets) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents ages 6--17 years old.” View full resource at oncologynurseadvisor.com
Most Recently Shared on January 10, 2011 at 4:17 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Kapvay available for ADHD http://goo.gl/fb/yyTjH
Shionogi brings KAPVAY ADHD drug to the U.S market
news-medical.net — “Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced a true milestone as it marks the first commercial availability for the non-central nervous system stimulant medication KAPVAY™, an extended-release oral formulation of clonidine for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents.” View full resource at news-medical.net
Most Recently Shared on January 10, 2011 at 7:50 pm By:
Pregnancy News: Shionogi brings KAPVAY ADHD drug to the U.S market: Shionogi Inc., the U.S.-based group company ... http://bit.ly/hPgK0h
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
ADHD Fever
A long and painful journey of failures in life only to discover that I had ADHD at age of 30. Now learning to adapt my ADHD to my work has made me shine!
-
Donna Petko, RN
Clinical Coordinator, MSN/FNP student, wife, mom. My interests include nursing, research, education.
-
Catherine K
Work in health publishing field. Passionate about healthy living.
Advertisement
